open access

Vol 69, No 6 (2018)
Original paper
Submitted: 2018-01-13
Accepted: 2018-05-25
Published online: 2018-09-21
Get Citation

Oncocytic neoplasms; rare adrenocortical tumours — a report of eleven patients

Hande Peynirci1, Bengür Taskıran2, Nagehan Dik3, Özlem Saraydaroğlu4, Canan Ersoy5
·
Pubmed: 30259505
·
Endokrynol Pol 2018;69(6):682-687.
Affiliations
  1. Department of Internal Medicine, Division of Endocrinology and Metabolism, Kastamonu State Hospital, Kastamonu, Türkiye
  2. Department of Internal Medicine, Division of Endocrinology and Metabolism, Yunus Emre State Hospital, Eskisehir, Türkiye
  3. Department of Internal Medicine, Bursa State Hospital, Bursa, Türkiye
  4. Department of Pathology, Uludag University Faculty of Medicine, Bursa, Türkiye
  5. Department of Internal Medicine, Division of Endocrinology and Metabolism, Uludag University Faculty of Medicine, Bursa, Türkiye

open access

Vol 69, No 6 (2018)
Original Paper
Submitted: 2018-01-13
Accepted: 2018-05-25
Published online: 2018-09-21

Abstract

Introduction: Oncocytomas of adrenal glands are extremely rare and usually present as incidentally detected masses. We aimed to present a series of patients with adrenal oncocytomas and review the literature.

Material and methods: Electronic database of patients with adrenal tumours, who were admitted to the internal medicine and endocrinology and metabolism outpatient clinics of Uludag University Medical Faculty between January 2005 and November 2016, were assessed retrospectively. Those who underwent surgery and pathological diagnosis of oncocytoma (n = 11) were included to the study. The demographic, clinical, pathological, radiological, and laboratory features were evaluated.

Results: Of these 11 patients, 54.5% (n = 6) were female and 45.5% (n = 5) were male. They aged between 31 and 76 years (45.36 ± 13.68). Five (45.5%) of the masses showed endocrinological activity and were more frequent in women. The masses were 25–130 (57.63 ± 34.04) mm in width and 20–100 (47.82 ± 28.95) mm in length. Seven (63.6%) oncocytomas were classified as benign and the remainder as having uncertain malignant potential according to Lin-Weiss-Bisceglia criteria. Mean duration of follow-up were 24.8 (6–60) months and 38.2 (15–82) months, respectively.

Conclusions: Because there are no unique clinical and imaging characteristics differentiating adrenal oncocytomas from other types of adrenal masses, it should be kept in mind in differential diagnosis of adrenal masses, especially large ones and those suspicious for adrenocortical carcinoma.

Abstract

Introduction: Oncocytomas of adrenal glands are extremely rare and usually present as incidentally detected masses. We aimed to present a series of patients with adrenal oncocytomas and review the literature.

Material and methods: Electronic database of patients with adrenal tumours, who were admitted to the internal medicine and endocrinology and metabolism outpatient clinics of Uludag University Medical Faculty between January 2005 and November 2016, were assessed retrospectively. Those who underwent surgery and pathological diagnosis of oncocytoma (n = 11) were included to the study. The demographic, clinical, pathological, radiological, and laboratory features were evaluated.

Results: Of these 11 patients, 54.5% (n = 6) were female and 45.5% (n = 5) were male. They aged between 31 and 76 years (45.36 ± 13.68). Five (45.5%) of the masses showed endocrinological activity and were more frequent in women. The masses were 25–130 (57.63 ± 34.04) mm in width and 20–100 (47.82 ± 28.95) mm in length. Seven (63.6%) oncocytomas were classified as benign and the remainder as having uncertain malignant potential according to Lin-Weiss-Bisceglia criteria. Mean duration of follow-up were 24.8 (6–60) months and 38.2 (15–82) months, respectively.

Conclusions: Because there are no unique clinical and imaging characteristics differentiating adrenal oncocytomas from other types of adrenal masses, it should be kept in mind in differential diagnosis of adrenal masses, especially large ones and those suspicious for adrenocortical carcinoma.

Get Citation

Keywords

adrenal incidentaloma; adrenal oncocytoma; Cushing syndrome; Conn syndrome; undetermined malignant

About this article
Title

Oncocytic neoplasms; rare adrenocortical tumours — a report of eleven patients

Journal

Endokrynologia Polska

Issue

Vol 69, No 6 (2018)

Article type

Original paper

Pages

682-687

Published online

2018-09-21

Page views

2791

Article views/downloads

1343

DOI

10.5603/EP.a2018.0066

Pubmed

30259505

Bibliographic record

Endokrynol Pol 2018;69(6):682-687.

Keywords

adrenal incidentaloma
adrenal oncocytoma
Cushing syndrome
Conn syndrome
undetermined malignant

Authors

Hande Peynirci
Bengür Taskıran
Nagehan Dik
Özlem Saraydaroğlu
Canan Ersoy

References (26)
  1. Mansmann G, Lau J, Balk E, et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004; 25(2): 309–340.
  2. Hamperl H. Oncocytes and the so called hurthle cell tumor. Arch Pathol. 1950; 49: 563–570.
  3. Kakimoto S, Yushita Y, Sanefuji T, et al. Non-hormonal adrenocortical adenoma with oncocytoma-like appearances. Hinyokika Kiyo. 1986; 32(5): 757–763.
  4. Smirnova EA, Mikhaĭlov IG. [Electron microscopic characteristics of oncocytoma of the lung, small intestine and adrenal gland]. Arkh Patol. 1986; 48(6): 79–81.
  5. Chang A, Harawi SJ. Oncocytes, oncocytosis, and oncocytic tumors. Pathol Annu. 1992; 27 Pt 1: 263–304.
  6. Chisté M, Poppiti RJ, Bianco FJ. Oncocytoma of the adrenal gland medulla. Ann Diagn Pathol. 2013; 17(1): 123–126.
  7. Godin K, Bang N, Tolkach Y. Case report: Heterotopic intrarenally located adrenocortical oncocytoma. F1000Res. 2014; 3: 73.
  8. Mearini L, Del Sordo R, Costantini E, et al. Adrenal oncocytic neoplasm: a systematic review. Urol Int. 2013; 91(2): 125–133.
  9. Bisceglia M, Ludovico O, Di Mattia A, et al. Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol. 2004; 12(3): 231–243.
  10. Gumy-Pause F, Bongiovanni M, Wildhaber B, et al. Adrenocortical oncocytoma in a child. Pediatr Blood Cancer. 2008; 50(3): 718–721.
  11. Wong DD, Spagnolo DV, Bisceglia M, et al. Oncocytic adrenocortical neoplasms — a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. Hum Pathol. 2011; 42(4): 489–499.
  12. Tartaglia N, Cianci P, Altamura A, et al. A Rare Case of Functioning Adrenocortical Oncocytoma Presenting as Cushing Syndrome. Case Rep Surg. 2016; 2016: 8964070.
  13. Kawahara Y, Morimoto A, Onoue A, et al. Persistent fever and weight loss due to an interleukin-6-producing adrenocortical oncocytoma in a girl--review of the literature. Eur J Pediatr. 2014; 173(8): 1107–1110.
  14. Sahin SB, Yucel AF, Bedir R, et al. Testosterone- and cortisol-secreting adrenocortical oncocytoma: an unusual cause of hirsutism. Case Rep Endocrinol. 2014; 2014: 206890.
  15. Lee SS, Baek KH, Lee YS, et al. Subclinical Cushing's syndrome associated with an adrenocortical oncocytoma. J Endocrinol Invest. 2008; 31(7): 675–679.
  16. Terui K, Sakihara S, Kageyama K, et al. A case of adrenocortical oncocytoma occurring with aldosteronoma. J Clin Endocrinol Metab. 2010; 95(8): 3597–3598.
  17. Sharma N, Dogra PN, Mathur S. Functional adrenal oncocytoma: a rare neoplasm. Indian J Pathol Microbiol. 2008; 51(4): 531–533.
  18. Shenouda M, Brown LG, Denning KL, et al. A Case of Oncocytic Adrenocortical Neoplasm of Borderline (Uncertain) Malignant Potential. Cureus. 2016; 8(6): e638.
  19. Ahmed MA, Sureshkannan KS, Raouf ZR, et al. Adrenal oncocytic neoplasm with uncertain malignant potential. Sultan Qaboos Univ Med J. 2013; 13(2): E334–E338.
  20. Tirkes T, Gokaslan T, McCrea J, et al. Oncocytic neoplasms of the adrenal gland. AJR Am J Roentgenol. 2011; 196(3): 592–596.
  21. Medeiros LJ, Weiss LM. New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review. Am J Clin Pathol. 1992; 97(1): 73–83.
  22. Lin BT, Bonsib SM, Mierau GW, et al. Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature. Am J Surg Pathol. 1998; 22(5): 603–614.
  23. Surrey LF, Thaker AA, Zhang PJ, et al. Ectopic functioning adrenocortical oncocytic adenoma (oncocytoma) with myelolipoma causing virilization. Case Rep Pathol. 2012; 2012: 326418.
  24. Song SY, Park S, Kim SR, et al. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004; 54(8): 603–610.
  25. Sangoi AR, McKenney JK. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am J Surg Pathol. 2010; 34(3): 423–432.
  26. Rutkowska J, Bandurska-Stankiewicz E, Kuglarz E, et al. Adrenocortical oncocytoma — a case report. Endokrynol Pol. 2012; 63(4): 308–311.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl